Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Valuate Health Consultancy is a private healthcare consulting firm focused on market access, reimbursement, evidence generation, value strategy, and commercialization support for drug, device, and diagnostics manufacturers. The company was launched in 2019 as the market access consultancy offering of Omnicom Health Group and serves healthcare and biopharma clients with a combination of payer expertise, analytics, and strategic advisory services. Its offerings include market access strategy, evidence and value services, pricing and contracting support, and proprietary analytics tools such as Cognuity, ECOsystem, Evidence Audit, Trends Reporting, and MARCO Rapid-response Payer Insights. Rather than developing its own therapeutic pipeline, Valuate helps clients demonstrate product value to payers and other healthcare stakeholders across the product lifecycle. The business appears to operate as an active private consultancy headquartered in Boston, Massachusetts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Valuate Healthcare Consultancy.